3-Phenylisoxazole-5-carboxylic Acid is a pharmaceutical intermediate typically used in the prepartion of PTI-428, which is a specific cystic fibrosis transmembrane conductance regulator (CFTR) amplifier.
Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis. [1]